These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36921746)

  • 41. Co-former selection for co-amorphous drug-amino acid formulations.
    Kasten G; Löbmann K; Grohganz H; Rades T
    Int J Pharm; 2019 Feb; 557():366-373. PubMed ID: 30578980
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
    Chavan RB; Lodagekar A; Yadav B; Shastri NR
    Drug Deliv Transl Res; 2020 Aug; 10(4):903-918. PubMed ID: 32378174
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved Dissolution Properties of Co-amorphous Probucol with Atorvastatin Calcium Trihydrate Prepared by Spray-Drying.
    Oyama S; Ogawa N; Kawai K; Iwai K; Yasunaga T; Yamamoto H
    Chem Pharm Bull (Tokyo); 2024; 72(2):190-199. PubMed ID: 38369345
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of the Polymer Glass Transition Temperature and Molecular Weight on Drug Amorphization Kinetics Using Ball Milling.
    Asgreen C; Knopp MM; Skytte J; Löbmann K
    Pharmaceutics; 2020 May; 12(6):. PubMed ID: 32471023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of preparation technique on co-amorphization of carvedilol with acidic amino acids.
    Mishra J; Löbmann K; Grohganz H; Rades T
    Int J Pharm; 2018 Dec; 552(1-2):407-413. PubMed ID: 30278256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exploring the physical stability of three nimesulide-indomethacin co-amorphous systems from the perspective of molecular aggregates.
    Wang M; Liu S; Jia L; Zhang J; Du S; Gong J
    Eur J Pharm Sci; 2020 Apr; 147():105294. PubMed ID: 32147483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Physicochemical properties of direct compression tablets with spray dried and ball milled solid dispersions of tadalafil in PVP-VA.
    Wlodarski K; Tajber L; Sawicki W
    Eur J Pharm Biopharm; 2016 Dec; 109():14-23. PubMed ID: 27658987
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The development of co-amorphous drug systems].
    Yao J; Shi NQ; Wang XL
    Yao Xue Xue Bao; 2013 May; 48(5):648-54. PubMed ID: 23888685
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two-phase amorphous-amorphous solid drug dispersion with enhanced stability, solubility and bioavailability resulting from ultrasonic dispersion of an immiscible system.
    Martínez LM; Videa M; López Silva T; Castro S; Caballero A; Lara-Díaz VJ; Castorena-Torres F
    Eur J Pharm Biopharm; 2017 Oct; 119():243-252. PubMed ID: 28648863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determination of Stable Co-Amorphous Drug-Drug Ratios from the Eutectic Behavior of Crystalline Physical Mixtures.
    Kissi EO; Khorami K; Rades T
    Pharmaceutics; 2019 Nov; 11(12):. PubMed ID: 31771255
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Preparation of amorphous indomethacin nanoparticles by aqueous wet bead milling and in situ measurement of their increased saturation solubility.
    Colombo M; Minussi C; Orthmann S; Staufenbiel S; Bodmeier R
    Eur J Pharm Biopharm; 2018 Apr; 125():159-168. PubMed ID: 29371046
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular dynamics, physical stability and solubility advantage from amorphous indapamide drug.
    Wojnarowska Z; Grzybowska K; Hawelek L; Dulski M; Wrzalik R; Gruszka I; Paluch M; Pienkowska K; Sawicki W; Bujak P; Paluch KJ; Tajber L; Markowski J
    Mol Pharm; 2013 Oct; 10(10):3612-27. PubMed ID: 24070615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of pressure on the intrinsic dissolution rate of amorphous indomethacin.
    Löbmann K; Flouda K; Qiu D; Tsolakou T; Wang W; Rades T
    Pharmaceutics; 2014 Aug; 6(3):481-93. PubMed ID: 25140536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
    Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
    Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Wet granulation of co-amorphous indomethacin systems.
    Schütz D; Timmerhaus A; Grohganz H
    Int J Pharm; 2023 Sep; 644():123318. PubMed ID: 37586574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
    Prasad D; Chauhan H; Atef E
    J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Investigating crystallization tendency, miscibility, and molecular interactions of drug-polymer systems for the development of amorphous solid dispersions.
    Meng F; Paul SK; Borde S; Chauhan H
    Drug Dev Ind Pharm; 2021 Apr; 47(4):579-608. PubMed ID: 33651659
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension.
    Surwase SA; Itkonen L; Aaltonen J; Saville D; Rades T; Peltonen L; Strachan CJ
    Eur J Pharm Biopharm; 2015 Oct; 96():32-43. PubMed ID: 26092472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development and characterization of a spray-dried inhalable ciprofloxacin-quercetin co-amorphous system.
    Alhajj N; O'Reilly NJ; Cathcart H
    Int J Pharm; 2022 Apr; 618():121657. PubMed ID: 35288220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.